SEC Form 4 · accession 0001144204-15-027937

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Medical Officer

Period of report

May 5, 2015

Accepted (ET)

May 6, 2015 · 3:54 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001077183

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	48,492	I	Albitar Oncology Defined Benefit Plan owns shares
Common Stock	holding	—	—		—	15,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4	$4.78	May 5, 2015	A	300,000	A	May 5, 2016	May 4, 2020	Common Stock	300,000	300,000	D
Stock Option (Right to Buy)^F1	$1.43	holding	—	—	—	Jan 9, 2013	Jan 9, 2017	Common Stock	250,000	250,000	D
Warrants (Right to Buy)^F2	$1.43	holding	—	—	—	May 9, 2014	Jan 9, 2017	Common Stock	200,000	200,000	D
Stock Option (Right to Buy)^F3	$3.45	holding	—	—	—	Mar 5, 2015	Mar 5, 2019	Common Stock	30,000	30,000	D

F1These stock options were granted upon the start of Dr. Albitar's service to the Company and vest ratably over each of his first four anniversaries with the Company.
F2These warrants were issued to Dr. Albitar upon the start of his service to the Company and vest upon the acheivement of certain milestones.
F3On March 5, 2014 Dr. Albitar was granted 30,000 stock options. The options vest ratably over the first three anniversaries of the grant date.
F4On May 5, 2015 Dr. Albitar was granted 300,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.